September 17, 2026
A peer-reviewed loperamide study has examined how variability in experimental ion-channel measurements affects QT predictions generated by sex-specific cardiac digital
September 3, 2026
Dr Jazmin Aguado-Sierra, Lead Scientist at ELEM Biotech, spoke with touchCARDIO about how digital models can reproduce different forms of heart
September 3, 2026
At ESC Congress 2026, Dr Jazmin Aguado-Sierra discussed where these tools could add value, and where questions around reliability
August 28, 2026
In this article, we explore the main themes of Jazmìn Aguado Sierra presentation during ESC 2026 - Electromechanical computational modelling of heart failure
May 23, 2026
In this study we investigate how experimental ion channel variability and extreme drug exposure jointly shape the concentration- QT relationship and proarrhythmic risk profile of
May 5, 2026
ELEM Biotech at ESC Heart Failure 2026, taking place 9-12 May 2026 in
April 4, 2026
Our results demonstrate the models’ capacity to accurately replicate flow dynamics. In addition, we illustrate how computational models can serve as valuable cross-checks to reduce noise and
March 10, 2026
Spain’s RedIA and RedIASalud Initiatives for the adoption of advanced technologies in healthcare: “Without public-private collaboration, innovation doesn’t reach real
March 10, 2026
Global initiatives advancing the adoption of Virtual Human Twins (Governmental investment and private
March 2, 2026
ELEM Biotech participated in MWC26 with three panels, taking place 2-5 March 2026 in
January 27, 2026
ELEM Biotech participated in EUCROF26, the 9th Annual Conference, which took place 1–3 February 2026 in Amsterdam, the
January 13, 2026
By accurately replicating pressure-volume loop characteristics and hemodynamic alterations commonly seen in clinical settings, this model enhances the understanding of HFrEF and may support the